赛托生物
(300583)
| 流通市值：26.71亿 | | | 总市值：27.22亿 |
| 流通股本：1.86亿 | | | 总股本：1.90亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 328,046,378.97 | 1,016,869,821.22 | 749,188,335.44 | 507,762,685.42 |
| 营业收入 | 328,046,378.97 | 1,016,869,821.22 | 749,188,335.44 | 507,762,685.42 |
| 二、营业总成本 | 320,008,510.91 | 1,055,969,458.02 | 796,360,986.67 | 543,997,518.64 |
| 营业成本 | 255,612,893.46 | 864,319,954.46 | 655,327,098.98 | 446,758,264.14 |
| 税金及附加 | 5,049,692.53 | 12,233,610.27 | 9,222,608.44 | 6,205,392.39 |
| 销售费用 | 6,430,014.7 | 11,036,043.42 | 9,462,575.93 | 5,742,915.21 |
| 管理费用 | 33,048,216.52 | 94,722,377.06 | 66,563,051.46 | 45,799,367.18 |
| 研发费用 | 10,112,695.2 | 41,543,067.14 | 32,249,551.03 | 22,455,004.72 |
| 财务费用 | 9,754,998.5 | 32,114,405.67 | 23,536,100.83 | 17,036,575 |
| 其中:利息费用 | 7,362,248.11 | 29,027,615.54 | 21,777,304.76 | 15,506,361.01 |
| 其中:利息收入 | 385,184.27 | 2,102,033.29 | 1,593,634.73 | 1,233,898.24 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 2,491,107.2 | 6,246,926.13 | 5,391,355.27 | 4,091,379.24 |
| 资产处置收益 | 217,907.39 | -824,300.99 | -165,020.44 | -162,577.53 |
| 资产减值损失(新) | -3,957,852.94 | -47,032,700.65 | -30,954,604.75 | -23,252,340.73 |
| 信用减值损失(新) | -3,411,569 | -6,041,112.37 | -9,637,137.21 | -4,740,822.13 |
| 其他收益 | 2,079,342.65 | 10,486,032.63 | 8,399,896.25 | 3,314,055.55 |
| 四、营业利润 | 5,456,803.36 | -76,264,792.05 | -74,138,162.11 | -56,985,138.82 |
| 加:营业外收入 | 1,054,261.78 | 34,365.65 | 10,613.64 | 9,406.99 |
| 减:营业外支出 | 48,283.18 | 834,043.79 | 1,073,659.07 | 533,322.95 |
| 五、利润总额 | 6,462,781.96 | -77,064,470.19 | -75,201,207.54 | -57,509,054.78 |
| 减:所得税费用 | 1,886,947.65 | 7,616,344.25 | 3,927,317.08 | 2,327,305.36 |
| 六、净利润 | 4,575,834.31 | -84,680,814.44 | -79,128,524.62 | -59,836,360.14 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 4,575,834.31 | -84,680,814.44 | -79,128,524.62 | -59,836,360.14 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,616,573.14 | -73,147,490.03 | -69,230,279.84 | -52,687,137.35 |
| 少数股东损益 | 959,261.17 | -11,533,324.41 | -9,898,244.78 | -7,149,222.79 |
| 扣除非经常损益后的净利润 | 1,708,880.23 | -76,650,429 | -72,387,914.43 | -53,481,635.07 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.02 | -0.39 | -0.36 | -0.28 |
| (二)稀释每股收益 | 0.02 | -0.39 | -0.36 | -0.28 |
| 九、综合收益总额 | 4,575,834.31 | -84,680,814.44 | -79,128,524.62 | -59,836,360.14 |
| 归属于母公司股东的综合收益总额 | 3,616,573.14 | -73,147,490.03 | -69,230,279.84 | -52,687,137.35 |
| 归属于少数股东的综合收益总额 | 959,261.17 | -11,533,324.41 | -9,898,244.78 | -7,149,222.79 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-29 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |